0.032
0.00 (-3.03%)
| Previous Close | 0.033 |
| Open | 0.033 |
| Volume | 58,850 |
| Avg. Volume (3M) | 719,154 |
| Market Cap | 37,076,372 |
| Price / Sales | 131.32 |
| Price / Book | 15.12 |
| 52 Weeks Range |
| Operating Margin (TTM) | -1,249.72% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -40.50% |
| Total Debt/Equity (MRQ) | 2.96% |
| Current Ratio (MRQ) | 3.52 |
| Operating Cash Flow (TTM) | -4.81 M |
| Levered Free Cash Flow (TTM) | -2.75 M |
| Return on Assets (TTM) | -91.62% |
| Return on Equity (TTM) | -317.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | HERAMED FPO [HMD] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | 0.00 |
Select this tab to load the latest available analysis.
|
HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 26.90% |
| % Held by Institutions | 4.43% |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |